BFO
Boston Family Office Portfolio holdings
AUM
$1.51B
This Quarter Return
+9.91%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$1.1B
AUM Growth
+$1.1B
(+7.1%)
Cap. Flow
+$29.5M
Cap. Flow
% of AUM
2.67%
Top 10 Holdings %
Top 10 Hldgs %
28.91%
Holding
248
New
4
Increased
57
Reduced
115
Closed
11
Top Buys
| 1 |
Apple
AAPL
|
$40.7M |
| 2 |
Zebra Technologies
ZBRA
|
$2.24M |
| 3 |
AbbVie
ABBV
|
$978K |
| 4 |
Stryker
SYK
|
$975K |
| 5 |
Relay Therapeutics
RLAY
|
$900K |
Top Sells
| 1 |
Middleby
MIDD
|
$2.62M |
| 2 |
Marsh & McLennan
MMC
|
$1.4M |
| 3 |
Amazon
AMZN
|
$1.01M |
| 4 |
Aflac
AFL
|
$1M |
| 5 |
Thor Industries
THO
|
$901K |
Sector Composition
| 1 | Technology | 22.19% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 9.14% |
| 4 | Industrials | 8.55% |
| 5 | Consumer Discretionary | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares Core S&P 500 ETF
IVV
$662B
| $2M | 0.18% | 5,946 +341 | +6% | +$115K |
|
102
Golar LNG
GLNG
$4.48B
| $1.91M | 0.17% | 316,149 -70,767 | -18% | -$428K |
|
103
Exxon Mobil
XOM
$487B
| $1.84M | 0.17% | 53,699 -12,725 | -19% | -$437K |
|
104
Alcon
ALC
$39.5B
| $1.8M | 0.16% | 31,521 -2,195 | -7% | -$125K |
|
105
Altria Group
MO
$113B
| $1.78M | 0.16% | 45,934 -2,905 | -6% | -$112K |
|
106
Oracle
ORCL
$635B
| $1.77M | 0.16% | 29,630 -4,598 | -13% | -$275K |
|
107
Hubbell
HUBB
$22.9B
| $1.77M | 0.16% | 12,910 -200 | -2% | -$27.4K |
|
108
Analog Devices
ADI
$124B
| $1.66M | 0.15% | 14,232 -129 | -0.9% | -$15.1K |
|
109
RTX Corp
RTX
$212B
| $1.66M | 0.15% | 28,821 -5,947 | -17% | -$342K |
|
110
AT&T
T
$209B
| $1.65M | 0.15% | 57,904 -81 | -0.1% | -$2.31K |
|
111
Diageo
DEO
$62.1B
| $1.64M | 0.15% | 11,939 +187 | +2% | +$25.8K |
|
112
Trane Technologies
TT
$92.5B
| $1.63M | 0.15% | 13,480 -75 | -0.6% | -$9.09K |
|
113
American Express
AXP
$231B
| $1.62M | 0.15% | 16,125 -193 | -1% | -$19.4K |
|
114
Kimberly-Clark
KMB
$42.8B
| $1.61M | 0.15% | 10,884 | – | – |
|
115
Novartis
NVS
$245B
| $1.59M | 0.14% | 18,325 | – | – |
|
116
Hologic
HOLX
$14.9B
| $1.54M | 0.14% | 23,145 -850 | -4% | -$56.5K |
|
|
SPLK
117
DELISTED
Splunk Inc
SPLK
| $1.49M | 0.14% | 7,915 +289 | +4% | +$54.4K |
|
118
IBM
IBM
$227B
| $1.45M | 0.13% | 11,885 -2,172 | -15% | -$264K |
|
119
Eli Lilly
LLY
$657B
| $1.44M | 0.13% | 9,715 -11 | -0.1% | -$1.63K |
|
120
Vanguard Large-Cap ETF
VV
$44.5B
| $1.42M | 0.13% | 9,047 -2 | -0% | -$313 |
|
|
LVGO
121
DELISTED
Livongo Health, Inc. Common Stock
LVGO
| $1.4M | 0.13% | 10,000 | – | – |
|
122
Illumina
ILMN
$15.8B
| $1.39M | 0.13% | 4,511 -25 | -0.6% | -$7.73K |
|
123
Welltower
WELL
$113B
| $1.37M | 0.12% | 24,925 -2,141 | -8% | -$118K |
|
124
Corning
GLW
$57.4B
| $1.35M | 0.12% | 41,496 -1,906 | -4% | -$61.8K |
|
125
VanEck Morningstar Wide Moat ETF
MOAT
$12.8B
| $1.34M | 0.12% | 24,460 -595 | -2% | -$32.5K |
|